Lymph node density as a prognostic predictor in patients with betel nut-related oral squamous cell carcinoma

Clin Oral Investig. 2018 Apr;22(3):1513-1521. doi: 10.1007/s00784-017-2247-3. Epub 2017 Oct 17.

Abstract

Objectives: Lymph node metastasis in oral squamous cell carcinoma (OSCC) is a poor prognostic factor. The histopathologic stage (e.g., pN) is used to evaluate the severity of lymph node metastasis; however, the current staging system insufficiently predicts survival and recurrence. We investigated clinical outcomes and lymph node density (LND) in betel nut-chewing individuals.

Material and methods: We retrospectively analyzed 389 betel nut-exposed patients with primary OSCC who underwent surgical resection in 2002-2015. The prognostic significance of LND was evaluated by overall survival (OS) and disease-free survival (DFS) using the Kaplan-Meier method.

Results: Kaplan-Meier analyses showed that the 5-year OS and DFS rates in all patients were 60.9 and 48.9%, respectively. Multivariate analysis showed that variables independently prognostic for OS were aged population (hazard ratio [HR] = 1.6, 95% confidence interval [95% CI] = 1.1-2.5; P = .025), and cell differentiation classification (HR = 2.4, 95% CI = 1.4-4.2; P = .002). In pathologic N-positive patients, a receiver operating characteristic (ROC) curve for OS was used and indicated the best cutoff of 0.05, and the multivariate analysis showed that LND was an independent predictor of OS (HR = 2.2, 95% CI = 1.3-3.7; P = .004).

Conclusions: Lymph node density, at a cutoff of 0.05, was an independent predictor of OS and DFS. OS and DFS underwent multiple analyses, and LND remained significant. The pathologic N stage had no influence in the OS analysis.

Clinical relevance: LND is a more reliable predictor of survival in betel nut-chewing patients for further post operation adjuvant treatment, such as reoperation or adjuvant radiotherapy.

Keywords: Betel nut; Lymph node density; Oral squamous cell carcinoma; Prognostic factor.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Areca / adverse effects*
  • Carcinoma, Squamous Cell / chemically induced*
  • Carcinoma, Squamous Cell / pathology*
  • Disease Progression
  • Female
  • Humans
  • Lymphatic Metastasis / pathology*
  • Male
  • Middle Aged
  • Mouth Neoplasms / chemically induced*
  • Mouth Neoplasms / pathology*
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Survival Rate